We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours Company (CC - Free Report) , a chemical company that has organized its business in three segments, namely, Titanium Technologies, Fluoroproducts and Chemical Solutions. With a Growth, Momentum and VGM score of “A”, the company has a whopping average positive surprise of 39.8%, with three beats over the last four quarters. It also is in the top 8% of its industry class and has an impressive expected five-year growth rate of 15.5%.
Align Technology Inc. (ALGN - Free Report) , designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. This company has one of the strongest medical technology success stories of the past year, with 27.8% sales growth in 2016 and an expected 25%+ top line ramp in 2017. First quarter company earnings, reported on April 27, confirmed that the growth story for the $11.4 billion maker of the revolutionary dental technology Invisalign is well intact. Its strong cash balance enables it to adopt attractive share repurchase programs.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
Image: Bigstock
Top Stock Picks for the Week of May 8th
Chemours Company (CC - Free Report) , a chemical company that has organized its business in three segments, namely, Titanium Technologies, Fluoroproducts and Chemical Solutions. With a Growth, Momentum and VGM score of “A”, the company has a whopping average positive surprise of 39.8%, with three beats over the last four quarters. It also is in the top 8% of its industry class and has an impressive expected five-year growth rate of 15.5%.
Align Technology Inc. (ALGN - Free Report) , designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. This company has one of the strongest medical technology success stories of the past year, with 27.8% sales growth in 2016 and an expected 25%+ top line ramp in 2017. First quarter company earnings, reported on April 27, confirmed that the growth story for the $11.4 billion maker of the revolutionary dental technology Invisalign is well intact. Its strong cash balance enables it to adopt attractive share repurchase programs.
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time.
One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>